In women, the window of implantation is limited to a brief 2-to 3-day period characterized by optimal levels of circulating ovarian hormones and a receptive endometrium. Although the window of implantation is assumed to occur 8 to 10 days after ovulation in women, molecular markers of endometrial receptivity are necessary to determine optimal timing prior to embryo transfer. Previous studies showed that members of the bone morphogenetic protein (BMP) family are expressed in the uterus necessary for female fertility; however, the role of BMP7 during implantation and in late gestation is not known. To determine the contribution of BMP7 to female fertility, we generated Bmp7 flox/flox -Pgr-cre +/-[BMP7 conditional knockout (cKO)] mice. We found that absence of BMP7 in the female reproductive tract resulted in subfertility due to uterine defects. At the time of implantation, BMP7 cKO females displayed a nonreceptive endometrium with elevated estrogen-dependent signaling. These implantation-related defects also affected decidualization and resulted in decreased expression of decidual cell markers such as Wnt4, Cox2, Ereg, and Bmp2. We also observed placental abnormalities in pregnant Bmp7 cKO mice, including excessive parietal trophoblast giant cells and absence of a mature placenta at 10.5 days post coitum. To establish possible redundant roles of BMP5 and BMP7 during pregnancy, we generated double BMP5 knockout/BMP7 cKO [BMP5/7 double knockout (DKO)] mice; however, we found that the combined deletion had no additive disruptive effect on fertility. Our studies indicate that BMP7 is an important factor during the process of implantation that contributes to healthy embryonic development. (Endocrinology 158: 979-992, 2017) S uccessful implantation requires a competent blastocyst and a receptive endometrium. As the first point of contact between the mother and developing embryo, the endometrium is essential for successful reproduction. Therefore, it is crucial to understand the factors and signaling pathways that contribute to endometrial receptivity. Hormones, such as estrogen (E2) and progesterone (P4), contribute to endometrial receptivity by inducing the proliferation and differentiation of endometrial stromal and epithelial cells. Finely balanced signaling by E2 and P4 define the "window of implantation," the period of time during which endometrial receptivity to an implanting blastocyst is optimal (1). The E2-and P4-mediated signals are transmitted via the steroid hormone receptors estrogen receptor a and progesterone receptor (2) and by other transcription factors such as COUP-TFII (3, 4) and Hand2 (5).
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In women, the window of implantation is limited to a brief 2-to 3-day period characterized by optimal levels of circulating ovarian hormones and a receptive endometrium. Although the window of implantation is assumed to occur 8 to 10 days after ovulation in women, molecular markers of endometrial receptivity are necessary to determine optimal timing prior to embryo transfer. Previous studies showed that members of the bone morphogenetic protein (BMP) family are expressed in the uterus necessary for female fertility; however, the role of BMP7 during implantation and in late gestation is not known. To determine the contribution of BMP7 to female fertility, we generated Bmp7 flox/flox -Pgr-cre +/-[BMP7 conditional knockout (cKO)] mice. We found that absence of BMP7 in the female reproductive tract resulted in subfertility due to uterine defects. At the time of implantation, BMP7 cKO females displayed a nonreceptive endometrium with elevated estrogen-dependent signaling. These implantation-related defects also affected decidualization and resulted in decreased expression of decidual cell markers such as Wnt4, Cox2, Ereg, and Bmp2.
We also observed placental abnormalities in pregnant Bmp7 cKO mice, including excessive parietal trophoblast giant cells and absence of a mature placenta at 10.5 days post coitum. To establish possible redundant roles of BMP5 and BMP7 during pregnancy, we generated double BMP5 knockout/BMP7 cKO [BMP5/7 double knockout (DKO)] mice; however, we found that the combined deletion had no additive disruptive effect on fertility. Our studies indicate that BMP7 is an important factor during the process of implantation that contributes to healthy embryonic development.
(Endocrinology 158: 979-992, 2017) S uccessful implantation requires a competent blastocyst and a receptive endometrium. As the first point of contact between the mother and developing embryo, the endometrium is essential for successful reproduction. Therefore, it is crucial to understand the factors and signaling pathways that contribute to endometrial receptivity. Hormones, such as estrogen (E2) and progesterone (P4), contribute to endometrial receptivity by inducing the proliferation and differentiation of endometrial stromal and epithelial cells. Finely balanced signaling by E2 and P4 define the "window of implantation," the period of time during which endometrial receptivity to an implanting blastocyst is optimal (1) . The E2-and P4-mediated signals are transmitted via the steroid hormone receptors estrogen receptor a and progesterone receptor (2) and by other transcription factors such as COUP-TFII (3, 4) and Hand2 (5) .
The TGFb family of proteins is a group of secreted factors that controls developmental processes such as cellular differentiation and proliferation and is highly conserved throughout evolution (6) . Bone morphogenetic proteins (BMPs) are members of the TGFb family and signal by binding to a receptor complex composed of two BMP type 1 receptors (ALK2, ALK3, or ALK6) and two type 2 receptors (BMPR2, ACVR2A, or ACVR2B) (7) (8) (9) . After BMP binding, the receptors phosphorylate SMAD1 and/or SMAD5, which then associate with SMAD4, and together translocate to the nucleus, where they control the expression of target genes in a context-dependent manner (10) .
Signaling through TGFb is important for female reproduction (11, 12) . Mouse models have demonstrated the contributions of various members of the TGFb family to uterine development and during pregnancy. For example, Tgfbr1/ALK5 is necessary for development of uterine smooth muscle and oviduct integrity (13) . Likewise, conditional deletion of Tgfbr1/ALK5 with progesterone receptor cre (Pgr-cre) results in severe subfertility with pronounced placental defects (14) . Uterine ALK4 is also important during late gestation, and its conditional deletion results in defective placental development and abnormal expansion of the giant trophoblast cells (15) .
In the uterus, the BMP signaling pathway is involved in the regulation of blastocyst implantation, endometrial stromal cell decidualization, and placental development (16) (17) (18) (19) . Uterine BMP2 (17, 20) and the BMP receptor ALK2 (16) are necessary for female fertility, and their conditional deletion prevents endometrial stromal cell decidualization. Conditional deletion of BMPR2 in the female reproductive tract results in growth-restricted embryos, abnormal uterine vascularization, and defective placental development (19) . ALK6 knockout (KO) mice are infertile, have cumulus cell expansion defects, and lack endometrial glands (21) . Conditional deletion of SMAD1, SMAD5, and the common SMAD4 with Amhr2-cre results in female sterility; the mice have abnormal smooth muscle development in the oviduct and myometrium and defective decidualization (22) . We recently showed that BMP signaling via ALK3 in the uterus is necessary for endometrial receptivity and that conditional deletion of ALK3 results in defective remodeling of the endometrial epithelium, abnormal response to E2 and P4, and sterility (18) .
Despite the crucial roles of the BMP type 1 and 2 receptors during pregnancy, the specific ligands that signal via the ALK3 and BMPR2 receptors are not yet known. Previous studies demonstrated that BMP2, BMP5, and BMP7 are expressed in the endometrium during the early stages of pregnancy (23) . BMP2 females are infertile and have decidualization defects that prevent embryo development beyond implantation (17) . BMP5 null mice were previously identified to be viable and fertile (24) . However, the role of BMP7 in the female reproductive tract and the possible redundant roles of BMP5 and BMP7 have not been assessed. Here we demonstrate that conditional deletion of BMP7 in the female reproductive tract results in female subfertility due to defects during the early stages of pregnancy. Specifically, we demonstrate that absence of uterine BMP7 results in a nonreceptive endometrium, which causes abnormal implantation that leads to additional defects throughout gestation, such as abnormal decidual gene expression, excessive expansion of the parietal trophoblast giant cells during placentation, and embryo resorption.
Materials and Methods

Mouse strains and breeding
Animal handling and all studies were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine. Because our studies are focused on the function of the female reproductive system, our studies were conducted on female mice. Wild-type (WT) mice were used in the studies where natural pregnancy was studied. The mice were maintained on a hybrid C57BL/6J and 129S5/SvEvBrd genetic background. Mice carrying the Bmp7 floxed alleles were generated by Dr. James Martin (25) . These mice have LoxP sites flanking exon 4, which encodes a portion of the BMP7 propeptide domain. Alleles of Bmp7 were checked by polymerase chain reaction (PCR) using the primers listed in Supplemental Table 1 using a 60°C annealing temperature; the WT and floxed alleles generated 230-and 270-bp PCR products, respectively. Bmp7 flox/flox mice were bred to mice expressing progesterone receptor-cre (Pgr-cre), generated by Dr. John Lydon (26) -/-(BMP5 KO) mice were genotyped by PCR amplification of the primers listed in Supplemental Table 1 , followed by ClaI restriction enzyme digest of the PCR product. PCR amplification of the WT allele resulted in a 291-bp product, whereas the C→T mutation in BMP5 KO mice destroyed the ClaI recognition site, resulting in a 570-bp PCR product. The C→T mutation in the BMP5 KO mice was also confirmed by DNA sequencing.
Fertility analyses
The fertility of BMP7 cKO, BMP5 KO, BMP5/7 DKO, and control mice was studied over the course of 6 months. BMP7 control, BMP7 cKO, BMP5 KO, and BMP5/7 DKO mice were mated with WT males. The presence of vaginal plugs in all the mice indicated normal mating, and the total number of pups and litters delivered were recorded.
Messenger RNA isolation and quantitative reverse transcription PCR analyses All tissues were frozen on dry ice immediately after collection. For RNA extraction, tissues were homogenized using an OMNI-TH tissue disrupter in RLT Lysis buffer using the RNeasy kit (QIAGEN). One microgram of RNA was then transcribed to complementary DNA (cDNA) using qSCRIPT cDNA supermix (Quanta) following the manufacturer's conditions. cDNA was diluted threefold, and 1 mL was used for PCR amplification with SYBR Green (Life Technologies/ABI) on a Roche 480 Light Cycler II. Primer sequences are listed in Supplemental Table 1 . Data were analyzed using the comparative Ct ( DD Ct) method as described by Schmittgen and Livak (27) and analyzed using a Student t test or analysis of variance analyses with Tukey's multiple comparison posttests using Prism GraphPad version 6.
Histology analyses
Tissues were fixed in 10% formalin overnight immediately after collection and then rinsed with 70% ethanol and processed for paraffin embedding in the Pathology and Histology Core Facility at Baylor College of Medicine. Paraffin sections (6 mm thick) were stained with hematoxylin and eosin (H&E; VWR) or with periodic acid-Schiff (PAS; Sigma) and hematoxylin.
Immunofluorescence and immunohistochemistry
The antibodies used in this study are listed in Table 1 and have an assigned Research Resource Identifier from the Antibody Registry. Prior to staining, sections were deparaffinized and rehydrated in Histoclear (VWR), 100%, 90%, 80%, and 60% ethanol, and water. Antigen retrieval was performed by heating tissue sections in 10 mM sodium citrate and 0.05% Tween-20, pH 6.0. Immunofluorescence detection was performed by incubating with primary antibody diluted in 3% bovine serum albumin overnight at 4°C. After washing in Tris buffered saline with Tween, Alexa-Fluor-594 or Alexa-Fluor-488-conjugated secondary antibodies were added (Thermo Fisher Scientific) for 1 hour at room temperature. 4',6-diamidino-2-phenylindole was added, and coverslips were mounted with Vectashield Fluorescence medium and imaged on an Olympus BX51 fluorescence microscope or on a Zeiss LSM 780 confocal microscope at the Optical Imagining and Vital Microscopy Core Laboratory at Baylor College of Medicine. For immunohistochemistry, we used the Avidin-Biotin Complex method (Vector Laboratories) using biotinylated secondary antibodies from Jackson Laboratories. Detection was performed using the 3-3 0 -diaminobenzidene horseradish peroxidase substrate (Vector Laboratories) and counterstained with Hematoxylin.
In situ hybridization
In situ hybridization was performed according to standard procedure (28) optimized for the BioLane HTI robotic system. Shortly, formalin-fixed and paraffin-embedded uterus sections were rehydrated through a series of xylene and ethanol. The plasmid containing the BMP7 cDNA sequence was linearized to produce sense and antisense digoxigenin-labeled RNA probes (digoxigenin RNA labeling kit, Roche) and processed through the slide in situ hybridization protocol.
Hormone treatments
Induction of superovulation was performed in 3-week-old control and cKO female mice by injection with 5 IU of equine chorionic gonadotropin. Forty-four to 46 hours later, mice were injected with 5 IU of human chorionic gonadotropin. Twentyfour hours later, the oviducts were collected, and the total number of ovulated oocytes was quantified.
We ovariectomized female mice and treated with exogenous hormones to induce the hormonal profile of pregnancy as previously described (29) . For these experiments, mice were ovariectomized, allowed to recover for 2 weeks, and then primed with 100 ng E2 (Sigma) dissolved in sesame oil. After 2 days of rest, the mice were treated with 1 mg P4 (Sigma) for 3 days, followed by a final injection of 1 mg P4 plus 50 ng E2 on the fourth day. The uteri were collected 15 hours after the final injection. The uterus was processed for histology or processed for epithelial and stromal cell isolation.
Hormone analyses
Serum was collected from 6-to 8-week-old mice at either 3.5 or 7.5 days post coitum (dpc) using cardiac puncture. After serum was separated from blood, it was stored at -80°C until analyzed. Serum levels of estradiol or progesterone were analyzed at the Ligand Assay and Analysis Core at the University of Virginia.
Epithelial cell isolation from the uterus
We followed a previously described protocol (16) . In brief, following the treatment with E2 and P4 to induce the hormonal profile of pregnancy, uteri were collected, cut into 2-to 5-mm cross-sections and incubated in 1% Trypsin (Sigma) dissolved in Hank's Balanced Salt Solution (Life Technologies). After a 30-minute incubation at 37°C, the epithelium of the uterus was mechanically separated from the stroma and myometrium using a mouth pipette and forceps. Purity of the epithelium was verified by the gene and protein expression analyses of cytokeratin 8 (epithelial marker) and vimentin (stromal marker).
Mechanical induction of decidualization
We followed a previously described protocol to perform mechanical induction of decidualization (30) . Briefly, mice were ovariectomized, allowed to recover for 2 weeks, and injected subcutaneously with 100 ng E2 for 3 days. Following 2 days of rest, mice were injected with 3 daily subcutaneous injections of 
Statistical analyses
In the figures, data are presented as mean 6 standard error of the mean (SEM). The experiments were performed in at least three different samples and were analyzed using Student t tests or analysis of variance with Tukey's multiple comparison posttests. Statistical analyses were performed in Excel or GraphPad version 6.
Results
Conditional deletion of BMP7 in the female reproductive tract results in subfertility BMP7 null mice perish in the perinatal period and demonstrate abnormal kidney function, eye defects, and defective skeletal formation (31, 32) . To study the role of BMP7 in the female reproductive tract, we used a conditional deletion approach by mating Bmp7 flox/flox female mice with Pgr-cre
by Pgr-cre results in the recombination of LoxP sites in the Pgr-expressing tissues, mainly the myometrium and endometrium of the uterus, the granulosa cells of the ovary, the mammary epithelium, and the anterior pituitary gland (26) . Quantitative reverse transcription (qRT)-PCR in the whole uterus showed that Bmp7 expression was significantly decreased in the cKO mice compared with the controls [ Fig. 1(B) ]. We found that the expression of Bmp7 increased during early pregnancy in the uterus of WT female mice [ Fig. 1(C) ], peaking at days 2.5 and 3.5 dpc. Likewise, Bmp7 was highly expressed in the decidua of WT mice at 5.5 dpc and decreased over the subsequent days [ Fig. 1(D) ]. In situ hybridization shows that Bmp7 is expressed in the stroma and epithelium of the nonpregnant uterus [ Fig. 1 (E-G)] and at 2.5 and 4.5 dpc [ Fig. 1(H-M) ]. BMP7 immunostaining revealed similar expression patterns, with BMP7 localized to both the epithelial and stromal compartments of the endometrium [Supplemental Fig. 1(A-L) ]. A 6-month fertility trial showed that the BMP7 cKO mice were subfertile compared with the control mice, having smaller litters than the controls (8.34 6 1.45 pups per litter vs 3.44 6 0.89 pups per litter, n = 6) and giving birth to fewer pups over the course of the 6-month trial (26.5 6 4.13 pups per control female vs 4 6 3.75 pups per cKO female, n = 6) ( Table 2 ). These results indicated that uterine BMP7 has an important role in female fertility. Normal ovarian function in control and cKO mice To determine the effects of conditional deletion of BMP7 on ovarian function, we induced superovulation in sexually immature female mice. Supplemental Fig. 2(A) shows that there was no significant difference in the total number of ovulated oocytes. We also analyzed the histology of the superovulated ovaries [Supplemental Fig. 2(B) ] and observed that the ovarian architecture was similar in ovaries from control and cKO mice. Serum levels of E2 and P4 in control and BMP7 cKO mice at 3.5 and 7.5 dpc showed no significant differences between the groups at either time point [Supplemental Fig. 2 (C) and 2(D)]. These results indicated that the subfertility defects in the cKO mice were not due to abnormal ovarian function.
Uterine BMP7 is important for normal pregnancy and fertility in mice
To determine the timing of the fertility defects in the cKO mice, we collected pregnant mouse uteri at various time points after mating. In Fig. 2(A-F) , we present the gross uteri from control [ Fig. 2 . We calculated the average weight of the implantation sites and found that although there was no significant difference in the weight of the implantation sites from 5.5 to 8.5 dpc [ Fig. 2(G) ], the weight of the implantation sites was significantly reduced at 10.5 dpc in the cKO mice compared with the controls (0.101 6 0.006 g vs 0.0645 6 0.006 g). To evaluate whether the implantation site defect across these time points was statistically significant, we calculated the rate of normal and resorbed embryos in control and BMP7 cKO mice at 8.5 and 10.5 dpc. We observed a significantly higher rate of resorbed implantation sites in the cKO mice at 8.5 dpc (2.1% in control vs 53% in cKO, P = 0.002) and 10.5 dpc (3.86% in control vs 90.3% in cKO, P , 0.0001) [ Fig.  2(H) ], indicating a significant defect during midgestation in pregnancies of BMP7 cKO mice.
BMP7 cKO show normal response to an artificial decidual stimulus
To assess the role of BMP7 in decidualization, we analyzed the response of the control and cKO mice to mechanical induction of decidualization (Supplemental Fig. 3) . We followed the experimental scheme indicated in Supplemental Fig. 3(A) to perform artificial decidualization of BMP7 control and cKO mice. Briefly, control and cKO mice were ovariectomized, allowed recovery for 2 weeks, and then treated with 100 ng estradiol (E2), followed by injections of 6.7 ng E2 plus 1 mg progesterone (P4). Decidualization was assessed 5 days after administration of the decidual stimulus. As shown in Supplemental Fig. 3(B) , we found no difference in the weight of the decidualized horns of the cKO mice compared with the controls. Grossly, we also observed no difference in the response to the artificial decidualization in the cKO mice compared with the controls [Supplemental Fig. 3 (C) and 3(D)].
BMP7 is important during the window of implantation
Because BMP7 expression was expressed during the window of implantation [ Fig. 1(C) ], we hypothesized that BMP7 played an important role during the process of implantation. To assess the role of BMP7 during the window of implantation, we analyzed the 4.5-dpc implantation sites of control and cKO mice. Transverse sections from control and cKO 4.5-dpc implantation sites were stained with H&E [ Fig.  3(A-D) ]. Histological analyses of the implantation sites showed that although the embryo was completely surrounded by the luminal uterine epithelium of the control mother [ Fig. 3(A) and 3(B) ], the embryo was detached and floating in the lumen of the cKO mother [ Fig. 3(C)  and 3(D) ]. Likewise, immunostaining of the 4.5-dpc implantation sites with the epithelial cell marker cytokeratin 8 (KRT8) and with the implantation marker cyclooxygenase 2 (COX2) showed defective attachment to the luminal uterine epithelium of the cKO mice [ Fig. 3 (G) and 3(H)] compared with the controls [ Fig. 3 (E) and 3(F)]. We also observed defective closure of the luminal uterine epithelium and extra luminal epithelial folds in the implantation crypts of the cKO mice compared with the controls [ Fig. 3(E-H) ].
Because defects in embryo implantation can be associated with an impaired response to the steroid hormones E2 and P4, we analyzed the expression of downstream E2 and P4 target genes. In Figure 3 (I), qRT-PCR analyses indicated significantly elevated expression of the downstream E2-activated genes lactoferrin (Ltf) and lipocalin 2 (Lcn2) in the implantation sites of cKO mice. However, we observed no statistically significant differences in the expression of the P4-activated genes wnt4, prostaglandin-endoperoxide synthase 2/cox2, bmp2, and epiregulin [Supplemental Fig. 4(A) ] or of the E2-activated gene mucin 1 (Muc1) between the control and cKO mice [ Fig. 3(I) ].
Signaling of Indian hedgehog (Ihh) and the chicken ovalbumin upstream promoter transcription factor II (COUP-TFII or Nr2f2) is crucial for the paracrine communication between the uterine epithelium and stroma during the window of receptivity (3, 4) . We observed no significant differences in the expression of Ihh and Nr2f2 at 3.5 dpc [Supplemental Fig. 4(B) ] or 4.5 dpc [ Fig. 3(I) ], indicating that defective uterine receptivity in BMP7 cKO mice was not the result of abnormal Ihh/COUP-TFII signaling. Levels of the gene encoding the critical receptivity factor leukemia inhibitory factor (Lif) were elevated in the cKOs at 3.5 dpc [Supplemental Fig. 4(B) ] but unchanged at 4.5 dpc [ Fig. 3(I) ]. Gene expression of the Lif receptor Lifr (33) was unchanged in the uteri of control and BMP7 cKO mice at 3.5 dpc [Supplemental Fig. 4(B) ] and 4.5 dpc [ Fig. 3(I) ]. Integrins are cell adhesion molecules that direct embryo/ uterine interactions during the window of receptivity and are critical for normal embryo implantation (34) . To determine the presence of any alterations in integrin or integrin ligand expression, we quantified their gene expression in the uteri of control and BMP7 cKO mice at 3.5 and 4.5 dpc. We observed no difference in the expression of CD44 (Cd44), integrin subunit alpha V (Itgav), integrin subunit beta 3 (Itgb3), integrin subunit beta 8 (Itgb8), L-selectin (Sell), or osteopontin (Spp1) between the uteri of control and BMP7 cKO mice at 3.5 dpc [Supplemental Fig. 4(C) ] or 4.5 dpc [ Fig. 3(I)] .
A hallmark of a receptive uterus is partly characterized by a nonproliferative luminal epithelium (2) . We used immunohistochemistry to analyze the expression of Ki67, a marker of proliferation, at 4.5 dpc. As shown in Figure 3 (J) and 3(K), the luminal uterine epithelium of the control mice was receptive, as indicated by a lack of Ki67 immunoreactivity and by the close association of the endometrium with the embryo. However, the luminal uterine epithelium of the cKO mice was 
BMP7 cKO mice show elevated luminal epithelial proliferation during the window on implantation
We treated ovariectomized control and cKO mice with E2 and P4 to simulate the hormonal profile of pregnancy [ Fig. 4(A) ] and to further analyze the hormonal response of the luminal uterine epithelium. Briefly, mice were ovariectomized and allowed to recover for 2 weeks followed by two injections of 100 ng E2. Following 2 days of rest, 1 mg of P4 was administered for 3 days, followed by a final injection with 50 ng E2 plus 1 mg P4. Uteri were collected 15 hours later. Unlike the controls [ Fig. 4 (B) and 4(C)], immunohistochemistry showed that the luminal uterine epithelium of the cKO mice was proliferative and nonreceptive, as indicated by positive Ki67 staining [ Fig. 4(D) and 4(E) ]. Likewise, qRT-PCR analysis showed that several markers of proliferation, including minichromosome maintenance complex component 7 (Mcm7), cyclin D2 (Ccnd2), cyclin D3 (Ccnd3), cyclin E2 (Ccne1), and cyclin E2 (Ccne2) were significantly elevated in the luminal uterine epithelium of cKO mice [ Fig. 4(F) ]. Previous studies show that the transcription factors KLF15 and KLF4 respond to steroid hormones and coordinate the proliferation of the luminal uterine epithelium by regulating Mcm2 and Mcm7 (29) . Gene expression analysis showed that Klf15 was significantly decreased in the luminal uterine epithelium of the cKO mice, while Klf4 and Mcm2 showed no difference [ Fig. 4(F) ]. These results suggest that BMP7 is a critical factor for uterine receptivity and is necessary to halt the proliferative response of the uterus.
BMP7 cKO mice show defective luminal closure and impaired decidual marker expression at 5.5 dpc
Because we detected high Bmp7 expression in the deciduae isolated from WT mice [ Fig. 1(D) ], we hypothesized that BMP7 also had a role in decidual function beyond the initiation of gross decidualization or in supporting embryo development during midgestation. To test this, we analyzed implantation sites from control and cKO mice at 5.5 dpc. Of note, we did not observe a difference in the number of implantation sites at 5.5 dpc (not shown). In Figure 5(A-C) , H&E staining of the control implantation sites showed complete luminal closure along Analysis of pregnancy and implantation sites 6.5 and 7.5 dpc We performed further analyses of the pregnant uteri from control and cKO mice at 6.5 and 7.5 dpc (Supplemental Fig. 5 ). Grossly, we observed increased resorbed implantation sites in the cKO mice at 6.5 dpc and increased numbers of hemorrhagic sites in the cKO mice at 7.5 dpc [Supplemental Signaling by BMP7 is important during embryo development at 8.5 and 10.5 dpc
To determine the roles of BMP7 in midgestation, we analyzed implantation sites from control and cKO mice at 8.5 and 10.5 dpc (Fig. 6) . H&E staining of 8.5-dpc implantation sites showed the presence of the ectoplacental cone (EPC) in the control and cKO mice; however, the size of the embryo and EPC was reduced in cKO mice [ Fig. 6 (A) and 6(B)]. Using H&E staining at 10.5 dpc [ Fig. 6 (C) and 6(D)], all layers of the mature placenta (decidua, giant cells, spongiotrophoblast, and labyrinth) were present in the implantation sites from control mice, whereas these layers were disrupted in the cKO mice. To clearly visualize the embryos in these implantation sites, we performed immunohistochemistry for KRT8, which is expressed early during development and can be detected in the mouse trophectoderm in postimplantation embryos (35) . Using KRT8 immunohistochemistry, we observed that the implantation sites from cKO mice were smaller [ Fig. 6 (G) and 6(H)] compared with the implantation sites from control mice [ Fig. 6 (E) and 6(F)]. At 10.5 dpc [ Fig. 6(I-L) ], the implantation sites from cKO mice did not have a fully formed placenta and instead had expanded trophoblast giant cells, a resorbing embryo, and an enlarged lumen (indicated by black arrows) in the antimesometrial side of the implantation site. The interior epithelium of the lumen was positive for KRT8.
Next, we assessed the expression of two markers of placental cell lineages: placental lactogen (PL1), a marker of parietal trophoblast giant cells, and trophoblast specific protein alpha (TPBPA), a marker of the spongiotrophoblast. At 8.5 dpc, the levels of PL1 expression were comparable between the control and cKO mice; however, cells of the EPC from the cKO implantation sites had decreased levels of TPBPA compared with the controls [ Fig. 6(M-P) ]. At 10.5 dpc, the placental defects were more pronounced, showing a drastic expansion of PL1-positive trophoblast giant cells and absence of TPBPA-expressing cells in the cKO implantation sites [ Fig. 6(Q-T) ], indicating the absence of the placental spongiotrophoblast layer.
To further characterize the development of 8.5-dpc embryos, we performed immunostaining of COX2 and smooth muscle actin (SMA) in implantation sites from control and cKO mice (Supplemental Fig. 6 ). COX2 is typically expressed around the endometrial stroma surrounding the embryo after implantation, while SMA is a vascular marker for the implantation site. There was no difference in the expression of COX2 between the implantation sites from control and cKO mice [Supplemental Fig. 6(A-D) ]. However, there was decreased immunoreactivity of SMA in the implantation sites from cKO mice [Supplemental Fig. 6(E-H) ], indicating impaired vascular development in the implantation sites from cKO mice. We also quantified the gene expression of the angiogenesis-stimulating ligands (36) vascular endothelial growth factors a through d (Vegfa, Vegfb, Vegfc, and Vegfd) in the implantation sites of 8.5-dpc control and BMP7 cKO mice [Supplemental Fig. 6(I) ]. We observed that the expression of Vegfa was significantly reduced in the implantation sites of BMP7 cKO mice [Supplemental Fig. 6(I) ]. However, the expression of the genes encoding the Angiopoietins 1-4 (Angpt 1-4), which function as angiogenic factors and control vessel maturation (37), was not statistically different between the control and BMP7 cKO implantation sites [Supplemental Fig. 6(J) ]. We also determined that the gene encoding the hypoxia-inducible factor 1a (hif1a) and its downstream regulated genes ankyrin repeat domain 37 (Ankrd37) and endoglin 1 (Egln1) were not significantly altered in the 8.5-dpc implantation sites of the BMP7 cKO mice [Supplemental Fig. 6(K) ].
Uterine natural killer (uNK) cells are typically present in the decidua, where they provide growth support to the decidual cells and remodel spiral arteries that supply blood flow to the developing embryo (38) . A subset of uNKs can be visualized with PAS staining or with Dolichos biflorus lectin (DBA) reactivity (39) . We localized uNKs with PAS [Supplemental Fig. 7(A-D) ] and DBA [Supplemental Fig. 7(E-H) ] in the 8.5-dpc implantation sites of control and cKO mice. We observed no differences in the intensity of the PAS or DBA reactivity between the controls and cKO mice, indicating normal uNK infiltration in the absence of uterine BMP7.
BMP5 does not compensate for the absence of BMP7
Our analyses of uterine BMP7 during pregnancy indicated that BMP7 had an important role during the process of implantation (Figs. 3 and 4) . However, because the cKO mice were subfertile, we hypothesized that other BMPs compensated for the absence of uterine BMP7. To test this hypothesis, we analyzed the expression of Bmp2, Bmp4, Bmp5, Bmp6, and Bmp7 in the endometrial stroma and epithelium of WT mice during the window of implantation (3.5 dpc) (Fig. 7) . Using qRT-PCR, we determined that Bmp5 was highly expressed at this time point (Fig. 7) . These results suggested that BMP5 might compensate for the absence of uterine BMP7 during the process of implantation. To test this, we obtained BMP5 knockout (BMP5 KO) mice (also known as "short ear"), which have a C→T mutation that creates a premature stop codon; this mutation results in a protein missing the BMP5-signaling mature domain (24) .
We bred BMP5 KO mice to the BMP7 cKO mice as shown in Figure 8 (A) to obtain BMP5 KO/BMP7 cKO (BMP5/7 DKO) mice. We genotyped the BMP5 KO mice [ Fig. 8(B) ] as described in the Materials and qRT-PCR analysis of Bmp2, Bmp4, Bmp5, Bmp6, and Bmp7 in isolated endometrial stroma and epithelium of WT mice at 3.5 dpc (n = 6). Data are plotted as mean 6 SEM.
Methods section, and we also sequenced the amplicon, which confirmed the presence of the C→T mutation in the BMP5 KO mice [ Fig. 8(C) ]. To assess the fertility of the BMP5/7 DKO mice, we performed a 6-month fertility trial in which we mated control and mutant females to WT males. Mating behavior was normal in the control and mutant mice as assessed by the presence of vaginal plugs. The fertility rates (Table 3 ) of the BMP5 KO mice (17.5 6 2.35 total pups per female, n = 6) were similar to the BMP7 control mice (26.5 6 4.13 total pups per female, n = 6). The fertility of BMP5/7 DKO females (4.83 6 2.64 pups per female, n = 6) was not significantly different than that of BMP7 cKO females (4 6 3.75 pups per female, n = 6; Table 3 ). These results indicate that BMP5 does not compensate for the absence of uterine BMP7 in female fertility.
Discussion
In this study, we showed that conditional deletion of BMP7 resulted in subfertility, likely due to the defects we observed at the time of implantation, during decidualization, and in placental development. Our work and that of others (23) shows that BMP7 is highly expressed in the uterus at the time of implantation and in the decidua of pregnant WT mice, supporting an important role for BMP7 in normal embryo implantation, decidualization, and placental development. BMP7 is highly expressed in proliferative phase endometrium of women, and its expression decreases as decidualization progresses (40), possibly to allow placental development (41) . These results and ours implicate BMP7 as an important factor during two key stages of pregnancy: in the transformation of the endometrium into a receptive state and during placental development. Previous studies show that defective embryo implantation affects normal embryonic development during midgestation and results in embryo loss (42) (43) (44) . Thus, the implantation defects in the BMP7 cKO mice may adversely affect pregnancy at midgestation, leading to defective decidualization and impaired embryo growth and placentation. Alternately, maternal BMP7 may be an important factor during midgestation, and its absence in BMP7 cKO mice could directly affect placental development.
Our results indicate that BMPs and their receptors have important roles throughout pregnancy. Previous studies showed that the endometrium of mice with conditional deletion of BMP2 and ALK2 does not decidualize, causing infertility (17, 20) . However, the absence of BMP7 only partially affected decidualization in the natural pregnancy and had no effect on the artificial induction of decidualization, suggesting that BMP2 and possibly other ligands are the primary TGFb family members driving decidualization. Further studies are needed to definitely demonstrate the role of BMP7 in decidualization.
We previously identified that signaling via the BMP type 1 receptor ALK3 is needed to prepare the endometrium for embryo implantation and that its conditional deletion from the reproductive tract results in sterility (18) . However, it is unclear which of the BMP family members signal via ALK3 during the window of implantation. Because mice with conditional inactivation of BMP2 in the female reproductive tract (17) do not phenocopy the mice with conditional ALK3 deletion (18) , it is possible that BMP2 is not the ligand necessary during the window of implantation, or that other ligands of the BMP family can compensate for its absence. Here we demonstrated that although conditional deletion of BMP7 resulted in pronounced defects during the process of embryo implantation, some embryos bypassed these defects and went beyond implantation. To ascertain that these results were representative of the genotype, we analyzed implantation sites from several BMP7 cKO mice and observed similar implantation defects to those described in Figure 3 (A-M) in five out of the eight sites we analyzed. This suggested two scenarios for the high number of embryos that could be observed at 5.5 dpc and beyond. First, it is possible that although most of the embryos from the BMP7 cKO females were detached at 4.5 dpc, they implanted later; this delayed implantation defect was previously observed in a mouse model with conditional inactivation of ALK2 (16) . Conditional deletion of ALK2 resulted in similar numbers of implantation sites at 4.5 dpc, with delayed implantation observed at 5.5 dpc and embryonic resorption by 7.5 dpc. Second, mice with conditional inactivation of WNT5a-ROR signaling (42) and RBPJ (44) demonstrate abnormalities during the peri-implantation period, and although the embryos implant, they perish later during gestation. Hence, it is possible that some embryos in the BMP7 cKO mice bypassed the defects observed at 4.5 dpc only to perish later during midgestation. Cumulatively, these studies and ours suggested that perturbations during the window of implantation lead to defects that are manifested during midgestation.
Compensation by another BMP family ligand could also explain the variable embryo implantation defects observed in the absence of uterine BMP7. To rule out the possibility of compensation by BMP5, which was highly expressed in the uterus during the window of implantation, we generated BMP5/7 DKO mice (Fig. 8) . The phenotype of double BMP5/BMP7 null mice suggests that unique signals are transmitted by the presence of both BMP5 and BMP7. Although BMP5 KO mice are viable and fertile (24) and BMP7 KO mice die perinatally due to kidney defects (31), double BMP5/BMP7 KO mutants are embryonic lethal due to defective chorioallantoic fusion (45) . However, our data showed that combined deletion of BMP5 and conditional deletion of BMP7 did not reduce the fertility of mice further than deletion of uterine BMP7 alone. Therefore, in the uterus, BMP5 does not compensate for the absence of BMP7 during pregnancy.
Defects during midgestation were also observed in BMP7 cKO females, including the abnormal expansion of the parietal trophoblast giant cells and absence of the mature placental layers at 10.5 dpc. Similar placental defects were observed in females with conditional inactivation of BMPR2 (19) , suggesting that BMP7 may be one of the ligands that signals via BMPR2 during midgestation. However, future studies will be needed to determine whether other BMPs, maternal or embryonic, also signal via BMPR2 during placentation.
Our understanding of endometrial receptivity in women has been greatly advanced by the use of animal models. Here, we generated a mouse model that demonstrates how maternal BMP7 is needed for the normal progression of pregnancy. These results highlight the importance of proper endometrial function for achieving uterine receptivity, decidualization, and placental development.
The endometrium is a dynamic tissue that is continuously remodeled throughout the menstrual cycle in response to steroid hormones and growth factors. Because a successful pregnancy requires an intact embryo as well as a receptive endometrium, the identification of clinical markers of endometrial receptivity before embryo transfer could improve the success rate of live births following embryo transfer in the assisted reproductive clinic. Our results contribute toward building a thorough understanding of the signaling pathways that coordinate uterine receptivity and can be used in the future to improve the treatment of female infertility through assisted reproductive technologies. 
